Price gouging on drugs? Shkreli's jury selection process reveals some deep public anger
If the US ever does pass laws prohibiting price gouging on drugs, pharma execs would be well advised to avoid any testing of the boundaries. There’s clearly a large segment of the public that’s ready to jail anyone who jacks up the price of a desperately needed treatment.
Harper’s magazine helped illustrate that point when they ran excerpts from the comments made by potential jurors in the Martin Shkreli case. Shkreli is notorious for raising the price of Daraprim by more than 5000%, and some of the prospective jurors were clearly ready to send him right behind bars — without any need for a trial.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.